Sebia USA reposted this
Don't miss our March 11th webinar featuring two leading experts who will compare the performance of sFLC assays in the contexts of Multiple Myeloma, including its precursors such as MGUS and smoldering myeloma, and Amyloidosis. With the introduction of updated guidelines for monoclonal gammopathies and a new, 2023 consensus for cardiac amyloidosis, attendees will gain valuable insights into the interchangeability of assay platforms and key considerations for optimizing testing triage. Earn Continuing Education (CE) credits for participating in this webinar. Register for free today! Sebia USA
